86 related articles for article (PubMed ID: 17226900)
1. Importance of performance status for treatment outcome in advanced pancreatic cancer.
Boeck S; Hinke A; Wilkowski R; Heinemann V
World J Gastroenterol; 2007 Jan; 13(2):224-7. PubMed ID: 17226900
[TBL] [Abstract][Full Text] [Related]
2. [Evaluation of therapeutic effect of chemotherapy with reference to clinical benefit response].
Okada S
Gan To Kagaku Ryoho; 2000 May; 27(5):696-701. PubMed ID: 10832437
[TBL] [Abstract][Full Text] [Related]
3. Neutrophil/lymphocyte ratio helps select metastatic pancreatic cancer patients benefitting from oxaliplatin.
Formica V; Morelli C; Ferroni P; Nardecchia A; Tesauro M; Pellicori S; Cereda V; Russo A; Riondino S; Guadagni F; Roselli M
Cancer Biomark; 2016 Sep; 17(3):335-345. PubMed ID: 27434293
[TBL] [Abstract][Full Text] [Related]
4. Survival after pancreatectomy for pancreatic adenocarcinoma is not impacted by performance status.
Mullinax JE; Hernandez JM; Toomey P; Villadolid D; Bowers C; Cooper J; Rosemurgy AS
Am J Surg; 2012 Nov; 204(5):704-8. PubMed ID: 23140830
[TBL] [Abstract][Full Text] [Related]
5. Impact of intensified chemotherapy in metastatic pancreatic ductal adenocarcinoma (PDAC) in clinical routine in Europe.
Javed MA; Beyer G; Le N; Vinci A; Wong H; Palmer D; Morgan RD; Lamarca A; Hubner RA; Valle JW; Alam S; Chowdhury S; Ma YT; Archibugi L; Capurso G; Maisonneuve P; Neesse A; Sund M; Schober M; Krug S
Pancreatology; 2019 Jan; 19(1):97-104. PubMed ID: 30529068
[TBL] [Abstract][Full Text] [Related]
6. Long-term outcome of patients with advanced pancreatic cancer treated with sequential chemotherapies before the era of modern combination therapy protocols.
Abendroth A; Noureddine R; Abramczyk M; Paul A; Gerken G; Schmid KW; Markus P; Schumacher B; Wiesweg M; Köhler J; Markus M; Mende B; Dechêne A; Schuler M; Kasper S
J Cancer Res Clin Oncol; 2019 Feb; 145(2):445-455. PubMed ID: 30430229
[TBL] [Abstract][Full Text] [Related]
7. [Current aspects of chemotherapy of metastatic pancreatic and biliary tract carcinomas].
Bokemeyer C; Kollmannsberger C; Oettle H; Kanz L
Praxis (Bern 1994); 2000 Sep; 89(39):1545-52. PubMed ID: 11068508
[TBL] [Abstract][Full Text] [Related]
8. Second-Line Treatment in Pancreatic Cancer Patients: Who Profits?--Results From the CONKO Study Group.
Sinn M; Dälken L; Striefler JK; Bischoff S; Schweitzer N; Pelzer U; Dörken B; Riess H; Stieler JM
Pancreas; 2016 Apr; 45(4):601-5. PubMed ID: 26646276
[TBL] [Abstract][Full Text] [Related]
9. Novel models for prediction of benefit and toxicity with FOLFIRINOX treatment of pancreatic cancer using clinically available parameters.
Schlick K; Magnes T; Ratzinger L; Jaud B; Weiss L; Melchardt T; Greil R; Egle A
PLoS One; 2018; 13(11):e0206688. PubMed ID: 30412592
[TBL] [Abstract][Full Text] [Related]
10. [Possibilities of palliation in pancreatic cancer].
Di Costanzo F; Sdrobolini A; Gasperoni S
Tumori; 1999; 85(1 Suppl 1):S47-53. PubMed ID: 10235081
[TBL] [Abstract][Full Text] [Related]
11. Survival analysis of 272 patients with pancreatic cancer undergoing combined treatment.
Cao N; Zhao A; Zhao G; Wang X; Han B; Lin R; Zhao Y; Yang J
Integr Cancer Ther; 2015 Mar; 14(2):133-9. PubMed ID: 25567328
[TBL] [Abstract][Full Text] [Related]
12. Systemic Combination Chemotherapy in Elderly Pancreatic Cancer: a Review.
Garcia G; Odaimi M
J Gastrointest Cancer; 2017 Jun; 48(2):121-128. PubMed ID: 28303435
[TBL] [Abstract][Full Text] [Related]
13. Advancements in the management of pancreatic cancer: 2013.
Saif MW
JOP; 2013 Mar; 14(2):112-8. PubMed ID: 23474549
[TBL] [Abstract][Full Text] [Related]
14. Duodenal stenting followed by systemic chemotherapy for patients with pancreatic cancer and gastric outlet obstruction.
Kobayashi S; Ueno M; Kameda R; Moriya S; Irie K; Goda Y; Tezuka S; Yanagida N; Ohkawa S; Aoyama T; Morinaga S; Morimoto M
Pancreatology; 2016; 16(6):1085-1091. PubMed ID: 27424479
[TBL] [Abstract][Full Text] [Related]
15. Predicting Survival After Irradiation of Metastases from Pancreatic Cancer.
Bolm L; Janssen S; Käsmann L; Wellner U; Bartscht T; Schild SE; Rades D
Anticancer Res; 2015 Jul; 35(7):4105-8. PubMed ID: 26124362
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors and sites of metastasis in unresectable locally advanced pancreatic cancer.
Peixoto RD; Speers C; McGahan CE; Renouf DJ; Schaeffer DF; Kennecke HF
Cancer Med; 2015 Aug; 4(8):1171-7. PubMed ID: 25891650
[TBL] [Abstract][Full Text] [Related]
17. Outcome and prognostic factors in patients with brain metastases from small-cell lung cancer treated with whole brain radiotherapy.
Bernhardt D; Adeberg S; Bozorgmehr F; Opfermann N; Hoerner-Rieber J; König L; Kappes J; Thomas M; Herth F; Heußel CP; Warth A; Debus J; Steins M; Rieken S
J Neurooncol; 2017 Aug; 134(1):205-212. PubMed ID: 28560661
[TBL] [Abstract][Full Text] [Related]
18. Chemotherapy and other supportive modalities in the palliative setting for pancreatic cancer.
Sullivan KM; Kozuch PS
Cancer J; 2012; 18(6):633-41. PubMed ID: 23187852
[TBL] [Abstract][Full Text] [Related]
19. Treatment outcomes for patients with glioblastoma multiforme and a low Karnofsky Performance Scale score on presentation to a tertiary care institution. Clinical article.
Marina O; Suh JH; Reddy CA; Barnett GH; Vogelbaum MA; Peereboom DM; Stevens GH; Elinzano H; Chao ST
J Neurosurg; 2011 Aug; 115(2):220-9. PubMed ID: 21548745
[TBL] [Abstract][Full Text] [Related]
20. Karnofsky performance status and lactate dehydrogenase predict the benefit of palliative whole-brain irradiation in patients with advanced intra- and extracranial metastases from malignant melanoma.
Partl R; Richtig E; Avian A; Berghold A; Kapp KS
Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):662-6. PubMed ID: 22901382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
